Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans

被引：9

作者：

Dodds, Melissa ^{[1
,2
]}

Maguiness, Sheilagh ^{[1
]}

机构：

[1] Univ Minnesota, Dept Dermatol, Div Pediat Dermatol, Minneapolis, MN 55455 USA

[2] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA

来源：

PEDIATRIC DERMATOLOGY | 2019年 / 36卷 / 04期

关键词：

acanthosis nigricans; epidermal nevus; FGFR3; topical sirolimus; GROWTH;

D O I：

10.1111/pde.13833

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

We present a 4-year-old developmentally appropriate boy with short stature and widespread expanding epidermal nevus with features of acanthosis nigricans. He was found to have a mosaic mutation in FGFR3, the R248C variant. Despite several therapies, he continued to have growth, fissuring, and bleeding of the affected skin. Ultimately, topical sirolimus was attempted and found to improve thickness and overall symptoms.

引用

页码：554 / 555

页数：2

共 5 条

[1] Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi
Hafner, Christian
van Oers, Johanna M. M.
Vogt, Thomas
Landthaler, Michael
Stoehr, Robert
Blaszyk, Hagen
Hofstaedter, Ferdinand
Zwarthoff, Ellen C.
Hartmann, Arndt
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (08) : 2201 - 2207
[2] FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes
Hafner, Christian
Di Martino, Erica
Pitt, Eva
Stempfl, Thomas
Tomlinson, Darren
Hartmann, Arndt
Landthaler, Michael
Knowles, Margaret
Vogt, Thomas
[J]. EXPERIMENTAL CELL RESEARCH, 2010, 316 (12) : 2008 - 2016
[3] Cutaneous Features of Crouzon Syndrome With Acanthosis Nigricans
Mir, Adnan
Wu, Timothy
Orlow, Seth J.
[J]. JAMA DERMATOLOGY, 2013, 149 (06) : 737 - 741
[4] Sirolimus: Its discovery, biological properties, and mechanism of action
Sehgal, SN
[J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 7S - 14S
[5] Genes, growth factors and acanthosis nigricans
Torley, D
Bellus, GA
Munro, CS
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (06) : 1096 - 1101

← 1 →